Cultured Thymus Tissue for Implantation (CTTI) ( DrugBank: - )

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
65原発性免疫不全症候群2

65. 原発性免疫不全症候群

臨床試験数 : 500 /  薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00579527
(ClinicalTrials.gov)		December 19, 200520/12/2007Phase I/II Thymus Transplantation With Immunosuppression #950Phase I/II Trial of Thymus Transplantation With Immunosuppression, #950DiGeorge Anomaly;Complete DiGeorge Anomaly;Complete Atypical DiGeorge Anomaly;Complete DiGeorge Syndrome;Complete Atypical DiGeorge SyndromeBiological: Cultured Thymus Tissue for Implantation (CTTI);Other: Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation;Procedure: Blood Draw;Drug: Rabbit anti-thymocyte globulin;Drug: Cyclosporine;Drug: Tacrolimus;Drug: Methylprednisolone or Prednisolone;Drug: Daclizumab;Drug: Mycophenolate mofetilEnzyvant Therapeutics GmBHNational Institutes of Health (NIH);National Institute of Allergy and Infectious Diseases (NIAID);Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)CompletedN/AN/AAll14Phase 1/Phase 2United States
2NCT00576407
(ClinicalTrials.gov)		October 199117/12/2007Thymus Transplantation in DiGeorge Syndrome #668Phase II Study of Thymus Transplantation in Complete DiGeorge Syndrome #668DiGeorge Syndrome;Complete Typical DiGeorge AnomalyBiological: Cultured Thymus Tissue for Implantation (CTTI)Enzyvant Therapeutics GmBHNational Institutes of Health (NIH);National Institute of Allergy and Infectious Diseases (NIAID);Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)CompletedN/AN/AAll26Phase 2United States